- Home
- ARWR vs ICLR Comparison
ARWR vs ICLR Comparison
Compare ARWR & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | ICLR |
|---|---|---|
| Founded | 2003 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 8.2B |
| IPO Year | 2009 | 2001 |
Fundamental Metrics
Financial Performance| Metric | ARWR | ICLR |
|---|---|---|
| Price | $74.16 | $102.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 13 |
| Target Price | $83.40 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 1.7M | 921.1K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.80 | N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $16,142,321.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $335.95 | ★ $12.91 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.44 | $66.57 |
| 52 Week High | $76.76 | $211.00 |
Technical Indicators
Market Signals| Indicator | ARWR | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 68.98 | 39.03 |
| Support Level | $60.60 | $95.75 |
| Resistance Level | $76.44 | $114.75 |
| Average True Range (ATR) | 3.01 | 4.91 |
| MACD | 0.99 | -0.33 |
| Stochastic Oscillator | 86.51 | 9.91 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.